— Know what they know.
Not Investment Advice
Also trades as: CO (NYSE) · $vol 1M

CORBF OTC

Global Cord Blood Corporation
1W: +0.1% 1M: +0.1% 3M: +0.1% YTD: +0.1% 1Y: -4.9% 3Y: -20.8% 5Y: -80.8%
$0.95
+0.00 (+0.00%)
 
Weekly Expected Move ±0.2%
$1 $1 $1 $1 $1
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 59 · $127.4M mcap · 117M float · 0.0042% daily turnover · Short 58% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$127.4M
52W Range0.2-1.75
Volume2,000
Avg Volume4,843
Beta-0.81
Dividend—
Analyst Ratings
1 Buy 2 Hold 0 Sell
Consensus Hold
Company Info
CEOTing Zheng
Employees1,202
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2007-05-09
Bank of China Tower
Hong Kong
HK
852 3605 8180
About Global Cord Blood Corporation

Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive testing, processing, and long-term storage of cord blood samples for its individual clients. Additionally, it undertakes the examination, preparation, and storage of donated cord blood units, facilitating their use for matching purposes. As of March 31, 2022, the corporation oversaw the management of three distinct cord blood banks, located in Beijing municipality, Guangdong province, and Zhejiang province. The entity previously operated as China Cord Blood Corporation, adopting its current name in March 2018, and functions as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms